Viewing Study NCT04927858


Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2025-12-31 @ 5:56 PM
Study NCT ID: NCT04927858
Status: COMPLETED
Last Update Posted: 2021-07-22
First Post: 2021-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
Sponsor: Boehringer Ingelheim
Organization: